Medtronic plc (MDT) operating KPIs

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value

$96.54−0.57 (-0.59%)

Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%

Medtronic fDA MAUDE Adverse Event Reports — U.S. Industry Total

Quarterly figures from Medtronic's filings and investor materials

Quarterly Annual Monthly

Latest, Q1 FY27

963,661

Period ended Jul 31, 2026

Change on a year earlier

+29.6%

743,346 in Q1 FY26

History

51 quarters

Since Q3 FY14

Sources

U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	FDA MAUDE Adverse Event Reports — U.S. Industry Total	Year on year	Source
Q1 FY27	Jul 31, 2026	963,661	+29.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY26	Apr 30, 2026	824,539	+26.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY26	Jan 31, 2026	784,473	+11.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY26	Oct 31, 2025	760,623	+7.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY26	Jul 31, 2025	743,346	+12.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY25	Apr 30, 2025	650,998	+8.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY25	Jan 31, 2025	704,375	+22.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY25	Oct 31, 2024	705,389	+15.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY25	Jul 31, 2024	660,962	+12.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY24	Apr 30, 2024	598,054	+5.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY24	Jan 31, 2024	575,423	+1.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY24	Oct 31, 2023	611,520	+7.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY24	Jul 31, 2023	589,956	-32.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY23	Apr 30, 2023	565,826	-33.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY23	Jan 31, 2023	569,850	-16.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY23	Oct 31, 2022	568,350	+21.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY23	Jul 31, 2022	879,152	+76.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY22	Apr 30, 2022	850,009	+69.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY22	Jan 31, 2022	680,159	+39.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY22	Oct 31, 2021	468,331	+13.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY22	Jul 31, 2021	498,655	+47.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY21	Apr 30, 2021	500,287	+38.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY21	Jan 31, 2021	488,207	+24.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY21	Oct 31, 2020	413,495	-0.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY21	Jul 31, 2020	337,352	+19.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY20	Apr 30, 2020	360,141	+32.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY20	Jan 31, 2020	391,212	+46.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY20	Oct 31, 2019	414,920	+43.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY20	Jul 31, 2019	281,535	+7.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY19	Apr 30, 2019	272,135	+13.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY19	Jan 31, 2019	267,679	+11.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY19	Oct 31, 2018	288,511	+22.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY19	Jul 31, 2018	262,459	+18.0%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY18	Apr 30, 2018	240,778	+0.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY18	Jan 31, 2018	240,403	+8.2%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY18	Oct 31, 2017	235,913	+1.9%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY18	Jul 31, 2017	222,451	+5.8%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY17	Apr 30, 2017	240,059	+9.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY17	Jan 31, 2017	222,132	+12.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY17	Oct 31, 2016	231,484	+4.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY17	Jul 31, 2016	210,345	-2.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY16	Apr 30, 2016	218,784	+2.7%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY16	Jan 31, 2016	197,615	-16.5%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY16	Oct 31, 2015	221,824	-11.4%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY16	Jul 31, 2015	215,652	+14.6%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY15	Apr 30, 2015	213,115	+11.3%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY15	Jan 31, 2015	236,533	+244.1%	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q2 FY15	Oct 31, 2014	250,402	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q1 FY15	Jul 31, 2014	188,149	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q4 FY14	Apr 30, 2014	191,450	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗
Q3 FY14	Jan 31, 2014	68,735	–	U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗

Cite this data

StockData. (2026). Medtronic FDA MAUDE Adverse Event Reports — U.S. Industry Total, quarterly Q3 FY14–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ext-fda-maude-ind

See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.